Kevin Camp

Kevin Camp serves as a key procurement professional within the Department of Health and Human Services, supporting the agency’s mission to advance public health through scientific innovation and operational readiness. He specializes in the acquisition of scientific and technical consulting services, managing complex contracts that enable evidence-based medical decision-making, laboratory modernization, and biotechnological research support. His work directly fuels the agency’s strategic priorities in molecular diagnostics and health infrastructure resilience, ensuring that mission-critical capabilities are delivered through rigorous, performance-based contracting practices. Camp maintains consistent partnerships with leading technical and biomedical contractors, including Leidos Biomedical Research Inc., General Dynamics Information Technology, Advanced Technology International, and Rapid Deployment Inc. These relationships are centered on high-complexity, knowledge-intensive services such as research support, data analytics, and biomedical systems integration. His contracting patterns reflect a preference for established, mission-aligned vendors with proven expertise in federal health science environments, fostering long-term collaboration over transactional engagements. Notably, Camp’s procurement activity is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a strategic focus on accessing the broadest possible pool of technical expertise rather than socioeconomic set-asides, prioritizing capability and capacity over certification-based preferences. His approach aligns with the agency’s need for scalable, high-caliber scientific support across time-sensitive and mission-critical initiatives. His primary procurement focus is on NAICS 541690—Other Scientific and Technical Consulting Services—encompassing bioinformatics, clinical research support, laboratory optimization, and health technology assessment. He routinely procures services that bridge scientific research with operational implementation, ensuring that cutting-edge biomedical innovations are effectively translated into public health outcomes through rigorous, compliance-driven contracting.